Efficacy and Safety of Ketamine-Dexmedetomidine Versus Ketamine-Propofol Combination for Periprocedural Sedation: A Systematic Review and Meta-analysis.

IF 3.2 2区 医学 Q2 CLINICAL NEUROLOGY Current Pain and Headache Reports Pub Date : 2024-04-01 Epub Date: 2024-01-12 DOI:10.1007/s11916-023-01208-0
Ahmed Saad Elsaeidy, Aya Hisham Moussa Ahmad, Neveen A Kohaf, Aya Aboutaleb, Danisha Kumar, Khaled Saad Elsaeidy, Ola Saeed Mohamed, Alan D Kaye, Islam Mohammad Shehata
{"title":"Efficacy and Safety of Ketamine-Dexmedetomidine Versus Ketamine-Propofol Combination for Periprocedural Sedation: A Systematic Review and Meta-analysis.","authors":"Ahmed Saad Elsaeidy, Aya Hisham Moussa Ahmad, Neveen A Kohaf, Aya Aboutaleb, Danisha Kumar, Khaled Saad Elsaeidy, Ola Saeed Mohamed, Alan D Kaye, Islam Mohammad Shehata","doi":"10.1007/s11916-023-01208-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>The combination of ketamine with propofol and dexmedetomidine has gained popularity for sedation and general anesthesia in different populations. In our meta-nalysis, we helped the anesthesiologists to know the efficiency and the efficacy of both combinations in adult and pediatric patients.</p><p><strong>Methods: </strong>We searched PubMed, CENTRAL, Web of Science, and Scopus from inception to August 1, 2023. Our outcome parameters for efficacy were recovery time, pain score, and physician satisfaction while for safety were the related cardiorespiratory, neurological, and gastrointestinal adverse events.</p><p><strong>Recent findings: </strong>Twenty-two trials were included with a total of 1429 patients. We found a significantly longer recovery time in the ketadex group of 7.59 min (95% CI, 4.92, 10.26; I<sup>2</sup> = 94%) and a significantly less pain score of - 0.72 (95% CI, - 1.10, - 0.34; I<sup>2</sup> = 0%). Adults had a significantly better physician satisfaction score with the ketofol group, odds ratio of 0.29 (95% CI, 0.12, 0.71; I<sup>2</sup> = 0%). Recovery agitations were higher in the ketofol group with an odds ratio of 0.48 (95% CI, 0.24, 0.98; I<sup>2</sup> = 36%). Furthermore, we found a significant difference between the combinations with a higher incidence in the ketadex group with pooled odds ratio of 1.75 (95% CI, 1.06, 2.88; I<sup>2</sup> = 15%). Ketadex was associated with lower pain scores, hypoxic events and airway obstruction, and emergence agitation. At the same time, ketofol had much more clinician satisfaction which might be attributed to the shorter recovery time and lower incidence of nausea and vomiting. Therefore, we suppose that ketadex is the better combination in periprocedural sedation for both adult and pediatric patients who are not at greater risk for postoperative nausea and vomiting.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940385/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pain and Headache Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11916-023-01208-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of review: The combination of ketamine with propofol and dexmedetomidine has gained popularity for sedation and general anesthesia in different populations. In our meta-nalysis, we helped the anesthesiologists to know the efficiency and the efficacy of both combinations in adult and pediatric patients.

Methods: We searched PubMed, CENTRAL, Web of Science, and Scopus from inception to August 1, 2023. Our outcome parameters for efficacy were recovery time, pain score, and physician satisfaction while for safety were the related cardiorespiratory, neurological, and gastrointestinal adverse events.

Recent findings: Twenty-two trials were included with a total of 1429 patients. We found a significantly longer recovery time in the ketadex group of 7.59 min (95% CI, 4.92, 10.26; I2 = 94%) and a significantly less pain score of - 0.72 (95% CI, - 1.10, - 0.34; I2 = 0%). Adults had a significantly better physician satisfaction score with the ketofol group, odds ratio of 0.29 (95% CI, 0.12, 0.71; I2 = 0%). Recovery agitations were higher in the ketofol group with an odds ratio of 0.48 (95% CI, 0.24, 0.98; I2 = 36%). Furthermore, we found a significant difference between the combinations with a higher incidence in the ketadex group with pooled odds ratio of 1.75 (95% CI, 1.06, 2.88; I2 = 15%). Ketadex was associated with lower pain scores, hypoxic events and airway obstruction, and emergence agitation. At the same time, ketofol had much more clinician satisfaction which might be attributed to the shorter recovery time and lower incidence of nausea and vomiting. Therefore, we suppose that ketadex is the better combination in periprocedural sedation for both adult and pediatric patients who are not at greater risk for postoperative nausea and vomiting.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
氯胺酮-右美托咪定与氯胺酮-丙泊酚联合用于围手术期镇静的有效性和安全性:系统回顾与元分析》。
综述的目的:氯胺酮与异丙酚和右美托咪定联合用于镇静和全身麻醉在不同人群中越来越受欢迎。在我们的荟萃分析中,我们帮助麻醉医师了解了这两种组合在成人和儿童患者中的效率和疗效:方法:我们检索了从开始到 2023 年 8 月 1 日的 PubMed、CENTRAL、Web of Science 和 Scopus。疗效方面的结果参数为恢复时间、疼痛评分和医生满意度,安全性方面的结果参数为相关的心肺、神经和胃肠道不良事件:最新研究结果:22 项试验共纳入了 1429 名患者。我们发现酮替克斯组的恢复时间明显更长,为 7.59 分钟(95% CI,4.92,10.26;I2 = 94%),疼痛评分明显更低,为- 0.72(95% CI,- 1.10,- 0.34;I2 = 0%)。克托福尔组的成人医生满意度评分明显更高,几率比为 0.29 (95% CI, 0.12, 0.71; I2 = 0%)。酮咯醇组的恢复期躁动程度更高,几率比为 0.48 (95% CI, 0.24, 0.98; I2 = 36%)。此外,我们还发现不同组合之间存在显著差异,酮替克斯组的发生率更高,汇总赔率为 1.75 (95% CI, 1.06, 2.88; I2 = 15%)。酮替塞与较低的疼痛评分、缺氧事件和气道阻塞以及出现躁动有关。与此同时,临床医生对凯多福的满意度更高,这可能是因为其恢复时间更短,恶心和呕吐发生率更低。因此,我们认为,对于术后恶心和呕吐风险不大的成人和儿童患者来说,酮替酯是围手术期镇静的更好组合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Pain and Headache Reports
Current Pain and Headache Reports CLINICAL NEUROLOGY-
CiteScore
6.10
自引率
2.70%
发文量
91
审稿时长
6-12 weeks
期刊介绍: This journal aims to review the most important, recently published clinical findings regarding the diagnosis, treatment, and management of pain and headache. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care and prevention of pain and headache. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as anesthetic techniques in pain management, cluster headache, neuropathic pain, and migraine. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.
期刊最新文献
Advances in the Treatment of Neuropathic Pain by Sympathetic Regulation. Methadone and Buprenorphine in the Perioperative Setting: A Review of the Literature. Use of Peripheral Nerve Blocks for Total hip Arthroplasty. Management of Post Dural Puncture Headache During Spinal Cord Stimulation Trials: A Review of Current Literature. Immune Competence and Pain: A Narrative Review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1